LETTER FROM LEADERSHIP
Letter from Leadership 2024
We had an exceptional year in 2023. Growth in the community outreach program, extraordinary faculty recognition, and the excellence of our Casey community continues to fuel our desire to invest in innovation. We’ve never been more committed to reaching our goal to end preventable blindness in Oregon and beyond. We are grateful for the opportunity to share exciting work from a few of our programs in this year's Innovations.
LETTER FROM LEADERSHIP
Letter from Leadership 2024
We had an exceptional year in 2023. Growth in the community outreach program, extraordinary faculty recognition, and the excellence of our Casey community continues to fuel our desire to invest in innovation. We’ve never been more committed to reaching our goal to end preventable blindness in Oregon and beyond. We are grateful for the opportunity to share exciting work from a few of our programs in this year's Innovations.
ADVANCING SURGERY
New Paths for Corneal Transplant: Clinical Trials at Casey Hold Global Promise
The cornea team at Casey Eye Institute seeks to shape the landscape of corneal transplant surgeries. New techniques and clinical trials will help design, select, and develop treatments that not only transform patient outcomes but change corneal health and vision restoration.
Advancing Imaging
Pioneering Optoretinography in Patients with Retinal Disease
A new imaging technique called OCT optoretinography (ORG) captured an image of photoreceptor dysfunction in a relatively wide area of 6x6 mm in the macula. ORG could provide a precise way to assess the effectiveness of therapies in earlier stages of the disease.
Advancing Gene Therapy
Clinical Trial Marks New Chapter for Gene Therapy
In the quest to cure inherited retinal diseases, OHSU Casey Eye Institute was the first in the world to use a new “spreading vector” technique in humans as part of a novel gene therapy clinical trial for treatment of X-linked juvenile retinoschisis (XLRS).
Inside the Lab
Stem Cell Research Offers Hope for Future Glaucoma Treatments
A collaborative research team is tackling glaucoma from a new angle – transforming patient-derived stem cells into retinal ganglion cells and then integrating them into explanted retinas. Ultimately, this could restore the critical connections impaired by glaucoma and revolutionize both early detection and treatment of the disease.
